543595 — EP Biocomposites Cashflow Statement
0.000.00%
Last trade - 00:00- IN₹215.15m
- IN₹237.67m
- IN₹114.39m
- 29
- 41
- 22
- 17
Annual cashflow statement for EP Biocomposites, fiscal year end - March 31st, INR millions except per share, conversion factor applied.
2020 March 31st | 2021 March 31st | 2022 March 31st | 2023 March 31st | 2024 March 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | PROSPECTUS | PROSPECTUS | PROSPECTUS | ARS | ARS |
| Standards: | IAS | IAS | IAS | IAS | IAS |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | 0.431 | 4.64 | 11.7 | 8.14 | 15.7 |
| Depreciation | |||||
| Non-Cash Items | 0 | -0.043 | 2.93 | 0.58 | -0.735 |
| Other Non-Cash Items | |||||
| Changes in Working Capital | 0.731 | -4.27 | -58.2 | -17.7 | -28.4 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Other Assets | |||||
| Change in Accounts Payable | |||||
| Change in Other Liabilities | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | 1.16 | 0.331 | -42.9 | -7.94 | -12.4 |
| Capital Expenditures | 0 | -0.027 | -4.74 | -0.224 | -2.36 |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | 0 | 0.043 | 0.159 | 0.448 | 0.728 |
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | 0 | 0.016 | -4.58 | 0.224 | -1.63 |
| Financing Cash Flow Items | -0.53 | 0 | -1.56 | -7.13 | -0.349 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | -0.005 | -0.025 | 47.6 | 28.1 | 4.86 |
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 1.16 | 0.322 | 0.081 | 20.4 | -9.22 |